Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is a trap set for sellers to come in? The lull about 30-40 min before market close
Congrats on your recent days loan Danish Dude. As for strategy forward given today's news, honestly I have not thought about it. For myself now I am thinking, I would not sell any shares before TLD, or before the price appreciates in the upper $1s like above $1.6. My loan gives me no urgency to pay it back as it is at less than 2% annual interest rate.
I do think a market cap around $1-2 billion would be acceptable for all parties concerned before TLD. That would translate to about $1-2 per share. If we can continue to have positive news, such as manufacturing license, the price will find more solid support.
All will change into a better scenario in terms of price if market dynamic changes due to strong demand for shares, such as one or two big guys are getting in big. In that case, it's possible to see price around $3 before TLD, in reference to the high of around $2.2 reached last year.
In a post I said yesterday, I stated now I have become accustomed to not reading tea leaves, or trying to speculate, and timing the market according to this and that anticipated event. I am determined to wait for TLD, while continue update DD.
Unless the fundamental changes, I am waiting for TLD.
But I would also like to say, it would not be a unwise move to sell the shares you bought lower to have liquidity and option on hand.
GL.
Time and time again it shows, it is wise for investors to be “fearful when others are greedy, and greedy when others are fearful.”
Guess my recent loan has been put in good use, not based on fear or greed, rather the underlining fundamental, which has not changed but only getting better.
Ladies and gentlemen the trial result will meet its primary and key secondary endpoints.
Thanks antihama. Happily have read your posts for a long time.
Ae kusterer, the problem to predict the timing of publication is there are many factors we simply don't know. So I try not to time it and just am happy it's now on the hand of peer reviewers.
As I said, one obvious unknown is whether there had already been some back and forth between peer reviewers and authors at the time of DI's reveal to the said poster in this board.
By now I have become accustomed to not reading any tea leaves or trying to timing any anticipated events, etc., which would not serve me well or any differently than being patiently awaiting company's official news and SEC filings as I think truly the day is coming soon (days, weeks, months are not a big different for me though).
In the meantime, one thing I may do is to add more shares in case of another bear raid, and the like.
GL to you and your group!
Appreciated very much for your well-thought out replies biosectinvestor. I understand where you are coming from. Yours is obvious a possible reason, though I think it may be somewhat a stretch.
There are different perceptions and perspectives on the same issue of pseudo progression from different parties. At the time of the partial halt, pseudo progression was already a known phenomenon for NWBio, clinicians running the trial, and regulatory agencies. The problem is when it happened to a patient there seemed to having no ways to distinguish either right on the spot or very shortly the event was in effect due to pseudo progression. So for the regulatory agencies, they had to assume it was a disease progression upon it was approved otherwise; for NWBio it could argue such events were most likely and mostly pseudo progressions, suggested by the underlining patients as a whole have instead lived longer than the rest of the patients in aggregate. So despite seemingly quick disease progressions (one characteristic for pseudo progression events) , these patients have also lived longer than those patients who have experienced disease progressions later (after the exclusion of rapid progression patients from the trial during the 3-month screening process, a characteristic for true disease progression events) which obviously contradicted to the known fact that disease progression normally correlates to underlining overall survival, i.e., the more delayed in disease progression, the longer the overall survival of underlining patients.
In light of the above, I don't think FDA when it initiated the partial halt would consider the halt a straight-forward safety halt. It might just want to give the company time to fix the problem or later provide it with more persuasive and convincing data that would indicate most such suspected events were indeed not harmful to the patients who have experienced the events. Since the halt was lifted by FDA, I do think NWBio was later able to provide to the FDA such data which not only has it showed the underlining patients have lived longer, but they also have experienced better quality of life.
It is in this sense and circumstance I also don't think the partial halt had anything to do with safety at the time. Today it can be said with almost certainty that both NWBio and FDA are on the same page regarding pseudo progressions, i.e., the more than expected disease progression events experienced in the trial are indeed mostly due to pseudo progressions; and it is also suggested NWBio may have found ways to distinguish between pseudo progressions and true progressions, evidenced by the listed second secondary endpoint in the now revised SAP, i.e., cPFS.
All in all, pseudo progression may be a strong indication that DCVax-L is not only safe by also very efficacious. It causes no harm to patients; instead it is a blessing.
GL and best wishes !
[There are not posts left for me today. Thank all]
Get well soon Danish Dude and your girlfriend. Enjoy the days as much as you both can.
I am planning celebration when all is known in a hugely positive way.
After a reflective Thanksgiving, please settle any uneasiness, preoccupation and most of all confusion resulted from the question: what on earth is "the reason behind the long delayed" TLD/publication. Today it has been well known about the phenomena of pseudo-progression and cross-over associated with most immunotherapeutic clinical trials.
As a result, the trials today can follow related regulatory guidance in design to circumvent the potential unfavorable effects of pseudo-progression and cross-over. But for a 15-year old trial which was data locked on 5 October 2020, its sponsor NWBio had no luxury back then. In light of the endless confusion still existing today, please allow me for a quick rehashing on what has been going on:
About in 2014-2015, the company finally realized its initial endpoints might be compromised due to recently known pseudo-progression phenomenon. Despite pseudo-progression in and by itself may actually indicate stronger than expected immunogenicity, i.e., it's inherently a good thing, it may wreak havoc with PFS as the primary endpoint.
Evidently, FDA halted the trial prohibiting the company from screening new patients in order to protect new patients from being harmed. Note any regulatory agency would not wait for the company to prove otherwise if they deem patients may experience harm. To get the trial halt lifted, the burden obviously fell upon NWBio to prove. NWBio's opinion obviously is there is no harm to any participated patients for the reason of pseudo-progression. Evidently in Feb 2017, FDA agreed with the company. As a result, it lifted the halt.
Concurrently with pseudo-progression, by the time the company also realized its initial overall survival secondary endpoint might also be compromised because by design patients in the trial would switch (cross over) to receiving DCVax-L vaccine at disease progression so that about 90% of all the patients enrolled have received DCVax-L. That may make accurately measuring the efficacy of vaccine problematic between both the control and treatment arms of patients.
In order to solve the two potential problems (pseudo-progression and crossover) above, it became natural and necessary for the company to revise its initial SAP in which trial endpoints are significant parts. Today we know both UK and Germany have accepted the changes, evidenced with their respective government responsible update in their clinical trial registries:
"The primary endpoint of this study is overall survival (OS) compared between patients randomized to DCVax-L and control patients from comparable, contemporaneous trials who received standard of care therapy only, in patients with newly diagnosed glioblastoma.
Secondary end point(s)
The first secondary endpoint is overall survival (OS) compared between patients randomized to placebo who received DCVax-L treatment following disease recurrence, and control patients from comparable, contemporaneous clinical trials, in patients with recurrent GBM.
The second secondary endpoint, confirmed progression-free survival (cPFS), is confirmed disease progression (cPD) compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study.
The third secondary endpoint, PFS, is progression-free survival compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study.
The fourth secondary objective, OS, is overall survival compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study.
The fifth secondary objective is tumor response compared between subjects randomized to DCVax®-L and those randomized to Placebo within Study."
Please note the initial primary and secondary endpoints are still part of the revised endpoints. It just now they are ranked the third and fourth endpoints (see above above).
So obviously NWBio will have plenty of explanation work to do to persuade and convince those who have doubts due to a variety of reasons. As a commercial company with only one product in the late stage development, it may not be rational and reasonable for the company to proceed in the direction of what seems familiar for most people: release TLD shortly after data lock, followed by publication/conference presentation, months if not years thereafter, considering the potential relentless malicious attacks the company had received in the past, because the trial results upon and after published will be most likely diced and spun in any negative way possible regardless how good the results will be.
This I think is the fundamental reason why we have been heading in this direction of making the trial data go through the multi-step reviews by "the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts, who will analyze the data with the statisticians in preparation for public announcement and scientific publication"
Obviously the well analyzed and reviewed trial results published in a peer reviewed journal will be hard to rebuff; In terms of getting the vaccine approved, it may, by carefully making the preparation of data now, save time in the end.
Recently we have known the publication is in the stage of journal peer reviews. Hopefully it will not take long to get the publication out to the public.
Personally, I have been a buyer, even recently having taken a loan since I don't see any other reason not doing so for myself of course. I can accept delayed rewards from my investment after carefully reviewing what we are at and the share price which I consider it close to the price if the trial would fail its primary endpoint. As I have stated many times on this board, it's highly probable the trial will readily meet its primary and key secondary endpoints significantly based on what have been known to the public.
All the above are just my humble opinions. Good luck and be happy everyone!
He has no chance today, and maybe never.
Buy as many as you can afford, I even encourage those who have not had a position yet because of lack of funds, take a small loan and start buying.
In this price range, we are already in "trial failure" range despite that will never come.
I don't know people, seemingly most are stupid at least from the standpoint of buying or selling nwbo stock.
Compete harshly with those deep pocketed!
And I must add GLTA since this is my last post for today.
Added 30k again to an already large pool of shares, still averaged up! The great divergent time is coming for nwbo regardless of the market and/or XBI. We will be golden, market proofed, that I believe.
I still think we will be golden today, not I care since I am long-term holder.
It's disastrous for traders in recent days, but today it will even be golden too for traders.
Buy as many as you can afford, compete harshly with the deep pocketed!
[Only three hours of trading left, hurry up!}
[We will meet both primary and key secondary endpoints handsomely when data is announced]
Today may be golden for nwbo because those who are deep pocketed as the market melts down generating fear and therefore shares to be scooped.
I will do that today if I am managing a mid-large sized fund, having done DD, and before waiting on sideline.
In the history of NWBO, most time its trading had been detached from the general market and even the XBI. It's just in recent months it has become in rapport somewhat with XBI.
Time to divorce again!
Thanks Doc, I shall feel more that way when things settle down.
The market seems in deny that DCVax-L trial will meet its primary and key secondary endpoints readily. With its pristine safety profile, DCVax-L will be approved for use around the world.
Best wishes
In the grand scheme of things, I can reconcile with the company for what we have obviously suffered from repeated unfulfilled promises, unprecedented stretches of everything a normal company would do, the vastly undervalued/suppressed equity values, for pretty much being thrown in the darkness from everything and anything shareholders normally have the right to be informed ...
if indeed after all have settled that the company does have some kind of rapport with FDA to move the company's affairs (solely DCVax-L trial data related, BLA, approval) strictly in accordance with the steps FDA has set up, and in lesser significance with the general GBM scientific landscape:
that FDA issued Draft Guidance: Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Guidance for Industry in December 2019, (waiting for finalization)
that WHO issued The 2021 WHO Classification of Tumors of the Central Nervous System, (new guidance for diagnosis, retrospective?)
A tacit agreement that NWBio has been set as an example, perhaps the first and only example as of today, to be applied to the new guidelines? In the grand scheme of things, that requires ultimate cautiousness:
that we have been put into this unprecedented QUIET PERIOD, and left to "die" without any life support from normal communications?
that NWBio has been indeed on AUTOPILOT with mystery force, and it can only do what is called in the best interest of shareholders, true or ironical?
If both RAs and NWBio are indeed heading in this direction in rapport, I can definitely reconcile for the best interest of all: first patients, new regulatory guidance for future clinical trials, and lastly NWBIo investors, as we may be part of the forces behind this paradigm shift regulatory and cancer treatment landscape.
As things come into light in days/weeks/months ahead, the market shall awaken in due course. Shareholders will finally be rewarded.
One other reason is that if the company can wait until the draft guidance Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Guidance for Industry is finalized and officially issued by FDA.
I appreciate the company's painstaking and meticulous cares of not in any way offending FDA, but after so much times has passed after data lock, the company should not be worry too much.
It is what it is. Let it be determined by data.
Nonetheless, I do understand their continued cautiousness.
This is my last post. Good night!
Thank you for sharing Survivor2012. Agreed with DI for most part, but besides a few shorts, I think most selling on recent days came from warrant holders (for some I may better call them former warrant holders) under generally unfavorable biotech environment (XBI has been 35% less from its peak for example).
As for why we have not seen big boys buying, I think if I were one big boy, I would not think the share price could drop any further. In this price range, I would think it's very attractive. So I would commit initiating buying about 1/3 of my target at any favorable convenient time so as to make sure I could achieve it at least cost possible. I would buy the rest after positive TLD/publication.
Because of that, I would be surprised if share price would not appreciate in a substantial way within days if there are indeed someones who think like and have significant financial resources in disposal; who have also done DD and currently on sideline.
Not that I care, since I have long determined to see long-term profit but cannot help...
Happy Thanksgiving!
Linda Powers Powerless As Of Now,
Island Boys n Vulture Funds Shitness As Always,
Retail Investors Hapless Ever Since Became Shareholders,
God Almighty corrects Wrongness,
That Linda Last Named Powers,
That Island Boys n Vulture Funds Last in History Archives,
That Retail Investors Last triumphant,
For Those Who Can See DCVax's Always Treasure Regardless!
[When this is being written, Island boy and vulture fund warrant holders are tearing down one wall to fix the other in a doomed losing battle!]
Do seller find a new contractor (MM) to sell? Hated by disgruntled Island boys and vulture funds?
[Has BiggerC bought any shares? has Thermo bought any shares? on autopilot?]
LOL, premature, naive, pity!
[it's good move by manipulator MMs to recoup the lost shares since Last Friday from buyers, including swing traders]
[Where are buyers DI, LesG?]
Just an observation re trading pattern:
Before, specifically days/months before last Friday's bear raid (not including Friday), OTCX is the culprit behind which sellers pay to hide to dump shares (I suspect the sellers are some warrant holders). But it seems during the process the sellers had been willing to sell at prices no lower than $1.0s.
OTCX has since been replaced since last Friday (including Friday) by other manipulators.
Meaning, the selling from some Island boy and vulture fund warrant holders had gone, which is responsible for share price decreasing from $1.6 all the way down to their line of hold which is slightly above $1.
Because of that, I simply predict we will readily reach $1 and above today, if not tomorrow.
We are golden, now as even Island boys and vulture funds are aligned with us diehard retail investors for not selling.
To some disgruntled sellers, you can prove me wrong by re-embarking on selling at your own peril!
spidaman, I definitely don't feel that way. Actually it's absurd. But honestly I don't know how high the share price will go immediately or in days after positive TLD/journal publication, because of numerous variables, such as the perception of the general market on data (is it good enough for FDA approval?), how and what is the reflection and interpretation of the mainstream media on the data/news/company, is the news usher in widespread institutional buying, and in what scales?
But safe to say, we have precedent cases to look at in pricing. One familiar example of course is Novocure (NVCR). Note nvcr is a device company which is usually less valued generally than a similar drug/biological product company in the market.
Novocure currently is valued around $10 billion, falling from as high as $25 billion when it peaked about five months ago. So at least $10 billion market valuation for nwbo is readily attainable. That will equate to about $8-10 per share for nwbo.
So I do think share price from $4-5 will be easily reached shortly after positive TLD/publication is announced.
After that how high the price will go it will be everyone's guess, but what I can say is it will go at least as high as $20, given it some time, perhaps a few quarters of steadily increased revenue and profit, if not earlier.
The price will be marked with the following milestones (not exactly in the order below):
manufacturing license, TLD/publication, [UK approval?], substantial financing, multiple trials with other indications, uplist to a major exchange, FDA approval, partnerships/outright buyout, demonstration of Q over Q increased revenues and profits, other major news
In the meantime, it will be rational and reasonable excitement and speculation on the trials and approvals of other indications using DCVax-L and DCVax-D, because of the nature of MOAs which should be able to duplicate on other indications, if not all, at least some.
I will retain most of my shares for a long time. GL!
My last post for today is dedicated to these rounded numbers for simplicity:
Share outstanding of nwbo: 1,000,000,000
Trading volumes recently: 3,000,000 - 4,000,000
Percentage of traded shares over SO each day: 0.3 - 0.4%
For God sake, it means nothing, nothing and nothing!
Calm down, take a walk, drink some your favorite drinks, make love, go on your routines; Guarantee you will not miss any tea leaves!!!
I agree all you have said in principle. On the other hand, if one looks the grand thing of DCVax trial data release from other angle, yes the quietness from the company may "kill" share price for a while such as no show in SNO (just a bag), but it actually shows strength, resolve and in effect imminent nature of news release as the company readily takes the pain of no showing, meaning journal publication may be really at the gate of letting go. And the bag, although not significant as someone had overthought over it, it's a way of advertisement: the company is well and just wait.
It also shows strength (not yet reflected on price yet) because the price has gone down so low that has reflected the price of "the worst case scenario, ie, only some subgroups are significant", a reasonable and average person would think the price now is very attractive, and will buy or add.
The only problem I see at the present in terms of softness in share price is that Island boys and vulture funds still have not had enough to "de-risk" by selling a portion of their legendary, almost freely collected shares (from converting warrants). These guys have no commitment, having not done (or never in their intention to do any) in-depth DD yet, no guts and no resources to "make the market" in any way, as they are a bunch of loose, selfish vultures who happened to all converge to nwbo a long time ago to exploit the worst situation years ago. In the process, collected huge piles of "free" warrants.
Nonetheless, they too will immediately switch from sell to buy as long as the market has a definite sign from the company: yes DCVax-L is indeed a go to FDA desk, either from journal publication, or else in official PR.
Trust me, in terms of reading tea leaves, or probing around either in a legal way or not, these vultures are much better at it than a few frequent tea leaf readers and overthinking posters on this board.
Fortunately things will not work that way. Relieved we are now in journal peer reviewing process, relieved we know from our DDs both primary and key secondary endpoints will be met significantly.
So I take the low price at present in stride, adding more or not.
GLTA!
Yea we should all calm down a bit, not stretching anything or everything as if we had not been stretched from this 15-year trial and unprecedented long analysis' grand 6-step process, which were recently happily accomplished as we now are waiting for peer reviews.
Noting good for digging out "signs" or "tea leaves" wandering beyond company's official news and SEC filing, prone to mistakes, or falling prey to exploiter's trap.
God, we know we have been waiting so long, but restlessness is definitely no go!
We are all golden as the bear raid is behind us, and "New Year" is coming.
WE ARE ALREADY WON LONG BEFORE THE BAG!!! If I have to specify when exactly we had already won, it's the publication on blended blinded data back in 2017, and its subsequent update in 2018, coupled with what we have known about this deadest disease and what the best of care or standard of care has done to this disease: nothing significant improvement has been made over the past decades !!
It is exactly at that time we know we have a winner!!!!
GLTUT eagle8! Please everyone beware of those same characters who reads, discovers, passes around, emphases, exaggerates the meaning of selected things in out of proportional manner. I believe some are genuinely believing, some may be just entertaining the board for a laugh, while some may just hoping in doing so they can close their swing trades readily in days... whichever the case I don't care. I care for only company's official news releases and SEC filings. From my decades long biotech investment experience, I know it's dangerous to go beyond that. So please beware!
Just like an old Chinese tea-leaf superstition: any emperor or great man when born, there must accompany with always colored clouds, beautiful phoenix birds flew by, or mystery blessing deeds, etc., while these nobles died, there were always preceding with earth shattering, massive dying evergreens, or unexplained senses of dismay, etc.
This board has become time consuming from unnecessary and rampant speculations, but even a broken clock is right twice a day, which maybe the principles behind all those constant useless speculations.
I am focused on long-term, and believe we will hear something significant directly from the company very soon!
here https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166839170
[[ Hutaaga Friday, 11/19/21 11:15:42 AM
Re: None 0
Post # of 419818
Thought I would share this with you.
Talked to Dave and spent good 25 mins this morning.
The summary is, it is now really is depend on the journal publication. If they release something early, it may jeoperdize the publication.
The holding is mostly due to these peer reviews were having hard times getting information because lots of the sources were shutdown due to covid.
Other than that, everything is lining up well.
So it is what it is.
He said they are working hard to stay on top of everything and trying to get it right, but can only do so much on their part.
He did mention that the average time from DL to publication is 13 months, so add a few months delays to that. ]]
Note: Flipper later talked to DI as well clarifying DI never said it would take several more months.
We are all golden now ladies and gentlemen given SNO self-inflicted, manipulators executed bear raid had been behind us:
Looking back, we must give Linda a genuine compliment for her very careful efforts of not giving any shreds of information which might have been mistaken by some shareholders that the company and related party would be presenting in this year's SNO. Despite that, unfortunately it seems she has failed, because some people may have been intentionally spreading misinformation, tossing around tea leaves to suggest otherwise, coupled with those usual one-line posters on social media yapping dismal price prediction day in and day out preceding the conference, hoping it would stick on investors mind.
Because of those bad actors, it validates company's strategy to painstakingly work on journal publication, not going the usual way to release short TLD, followed by journal publication several months or years after.
It's great it has gone, and it's great we don't need to look forward to next conference or ASCO. According to DI, the publication is now in peer reviews, which means the six huge steps outlined in the consistent company's news releases since included 5 October 2020 news have been successfully accomplished. Now we are in autopilot indeed!
Be patient ladies and gentlemen, this may take some times for the reviewers to complete their job and make their decision based on the nature of this 15-year long trial with an indication so heterogeneous.
However, since we don't know exactly when the company submitted the draft to journal, and whether there is already some back and forth interaction between the authors and the journal, so timing wise, it could be in very short time (one or two weeks) or some more time before publication. Nonetheless, be happy the big task of analyzing the trial data has been accomplished!
Lastly, as always we have reasons to believe DCVax-L is both efficacious and safe in treating GBM, one of the most difficult to treat cancers based on what we have known so far;
Due to the unique MOA of DCVax-L, it is most likely the therapeutic vaccine will usher in a new era of cancer cares and treatments. It will truly be personalized in which each individual patients own immune cells will be mobilized to kill cancer cells; and
During this long, difficult and rewarding journey, beware of those bad actors, and those who would exploit in any ways via any means!
Gook luck, I seeing the light!
It seems it has been some time in the making for today's raid. Bad actors chose today since they believe the company would not present in this year's SNO, unlike some retails who have repeated set them up for attack by believe otherwise. They have done their DD to confirm that, trust me they have made more phone calls than retails to dig around.
And you also have this environment in which the company relies on cash from huge warrant exercise, and the warrant holders would sell more or less at least a portion.
In the meantime, they instruct their one-line message board agents to try anyway possible to stick some random bizarre and bleak price prediction on message boards day in and day out.
After confirmed yes indeed this year's SNO the company would not present, then the raid started.
Missed board this morning, but still happy to have bought in these prices!
I do agree with DI once that the shorts rely on weak hands. Indeed, when manipulators got their hand full like today, and price dropped like no bottom, many longs started to even doubt if data is negative, or at least DI said data was not negative otherwise the 4-day rules would apply...
Man what I can say, It just approve what DI said is absolutely right that the shorts rely on the weak hand.
Because it's not easy for any stocks to can get rid of weak hands, plus bad actors writing one line bleak price prediction day in and day out all over the message boards, so what happened today is what it is, and it may happen again in the future.
Beware of those proliferate one-line posters of whom some may show "proof" of a large holding, but day in and day out try to stick bleak price prediction into message boards, I have not doubt some are footing for manipulator actors behind the scene.
But, and a big but, do you guys have really done your own DD. If yes, please correct me:
The primary and key secondary endpoints will be readily med significantly. Doesn't this statement change with share price? if yes, please go back to do your own DD.
Linda sucks for not communicating well with shareholders and the market, but please take a breath, and get dry powder ready all the time.
It will be simple: the price will go up to $1, $2, $3, $4, $5....thanks to the science and the information we have had today.
It's a strong buy, Never a doubt in my mind.
Wow, wow and wow, went to Costco this morning missing the board!
So the bad actors who pay to hide behind OTCX got bolder to take the stop-loss sells.
So those who have closely monitored and bought in the dip are truly luck ones.
Congratulations!!
This is my last post for today (I am restricted). Thank you for answering the q. All the best.
Thanks. It's indeed interesting to know how people have been doing in terms of their holding as we wait, wait and wait, knowing one day will be the day, but for this there will be no shreds of doubt will happen.
It's also interesting to know, much more than what people have said, their true actions as a result of their DDs and tolerance levels, all to be readily revealed with their respective net holding.
For that matter, Biggers and Thermo's holding is interesting to me as both are big holders with one being frequent twitter promoter while the other post in this board from time to time (in convenient time maybe?)
I am currently on loan with that I have bought shares recently. All in all, I am up big from my and my family's holding of which mostly have been bought low, but a significant numbers of shares fall in the category of averaging up buying started from price as high as in the $1.6s.
GLTA!
SURVEY: Please answer honestly and sincerely the following simply question:
Have the net shares of your nwbo holding increased, peaked or decreased as of today?
I will answer it first:
The net of my and my family's holding has steadily increased and peaked as of today.
Please answer. Thanks. I particularly am interested in Biggers and Thermo's answer as I suspect they both have lightened their respective holdings.
Big boys who are currently on sideline and want to get in big, quick and cheap have tightly controlled the price for obvious reason.
It's all nwbo management's failure to have failed to attract any serious funds to get in the beautiful nwbo land so far. so no counterweight.
The biggest beneficiaries Linda Powers and her friendlies Island boys and vulture funds in the meantime have gone in protracted quiet period:
Linda has self-imposed a quiet period which usually lasts from a couple of weeks to a couple of months, and now has been more than a year. It may be legitimate reasons behind it, I truly believe Covid is one of them. It also believe sincerely it is really unpredictable for the company to go through those six steps specified for data to be ready. Jesus, those academics, KOL are a bunch of egoistic organisms who will tear down anything you ask them to review --- given that, no complain really.
But one other biggest beneficiaries Island boys and vulture funds are really a thorn on the side of the collective well-being of all investors, ironically themselves included.
Only relief is on horizon. I am waiting. No problems!
Joseph Cofer Black: I am following up with my yesterday's message to you. Have you read it or has DI forward it to you?
As some bad actors pay to be hid behind OTCX manipulating nwbo stock for almost a year now, you are paid to dig them out, smoke them out.
Please do your job for the sake of those 2 million options you have been rewarded.
Linda is good for herself, you guys board of directors, her friendlies vulture financiers, but not yet to the vast number of nwbo owners us retail investors yet.
Regardless, please do your job.
Interpretation: I have sold enough, so of course no yapping, autopilot, it will be what it will be.
Typical one (vulture fund friend) of Linda's friendlies Island boys and vulture funds. No commitment, No deep DD or No ability to do deep DD, and importantly NO Guts.
The recent trading pattern, particularly the one after 10Q is very encouraging and positive for me, because when big players don't want the price to increase, let alone substantial one, that means they are currently on the sideline, and wait for the good news to get in big and quick.
In the meantime, Island boys and vulture funds are on autopilot (parasite). No guts, resources and intelligence to protect own position.
Purely because price movement (tightly suppression at any cost) , I give SNO surprise announcement 30% shot, 60% by year end, and 100% early next year.
Doesn't matter for me though, I will sell no shares before that to happen.
As Mr. Bigger seems to be unsure about the positive outcome, I am quite sure of the outcome; only thing I am not sure is how big a surprise it will show!
After the news, hope Ms Linda Powers completely severs her relations with these Island boys and vulture funds once for all!
Joseph Cofer Black: for about 2 million free options you have been rewarded, what have you been doing?
A new task for you: please go dig a bit deep into OTCX's market manipulating scheme. According to my observation, this has been going on for almost a year!
There seem to be some bad actors hiding behind OTCX, manipulating the stock, and it may be illegal.
Get some evidence or give them a warning for the sake of those 2 millions of options you have been rewarded!
I still stick to my observation and prediction that we will close green today.
On the other hand, if Linda's friendlies Island boys and vulture funds no longer selling, share price will be easily reaching $2;
If retail buying and selling net is positive, share price will be easily $3 built on top of Linda's friendlies no longer selling;
If instead both Linda's friendlies Island boys and vulture funds and us retail buying and selling is significantly positive, the price will be easily $3.5;
Those share price range can also be reached readily if Linda updates US registry with updated endpoint changes.
Then, with positive trial data release in whatever form, the share price will easily go as high as $5 initially, followed by $4 and then $5 again, then $6, ... $10, and never looking back, with short covering, and more confirmation plus most importantly serious funds came in.
Yes, only sky's the limit!
Today's trading pattern is clear: there is a force who never shows up on the ask but is willing to sell at any cost to the bid price. In the meantime, there is always a show of support, although not strong enough, of constantly showing up at the bid side. From the speed and steadiness, I don't think it's the retail who show up in support or should I say, retreated support (doesn't exclude a few brave and committed retails who do buy this morning).
Based on that observation, I do think today is the day one can call it a purely manipulated day.
If the support is consistently there, and Linda's friendlies Island boys and vulture funds would not join force with those who determine to sell at any cost to the bid, then today must be a green day.
All the above doesn't matter for me, since I am a believer and don't time the market for each of my buy; I am buying when price is depressed, peaking my holding for the inevitable day.
That day may be any day now, which I truly believe. If not, I will go on my routine to buy shares to peak my holding, or just simply waiting.
Nice to know you are still around. Good luck to you and your family!